首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Preparation and evaluation of kaempferol-phospholipid complex for pharmacokinetics and bioavailability in SD rats
【24h】

Preparation and evaluation of kaempferol-phospholipid complex for pharmacokinetics and bioavailability in SD rats

机译:山emp酚-磷脂复合物的制备及对SD大鼠药代动力学和生物利用度的评价

获取原文
获取原文并翻译 | 示例
           

摘要

As one of the dietary flavonoids, kaempferol (KP) has been well known to show strong anti-oxidative effect along with other biological properties. However, the oral bioavailability of KP is relatively low due to its poor solubility. In this study, we intended to increase the solubility and bioavailability of KP by preparing kaempferol-phospholipid complex (KP-PC). The KP-PC's physicochemical properties were characterized in terms of infrared spectroscopy (IR), differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD), water-Octanol solubility and in vitro dissolution. KP-PC exhibited higher solubility and dissolution rate than KP, indicating a significant improvement in hydrophilicity. A UPLC-ESI-MS/MS method was developed and validated for the determination of KP in Sprague-Dawley (SD) rat plasma, so as to investigate the oral bioavailability of KP-PC versus KP. Results showed that C-max and AUC(0-48h) of KP from the complex (C-max: 3.94 +/- 0.83 mu g/mL, AUC(0-48h): 57.81 +/- 9.43 mg/Lh) were higher than that of KP (C-max: 1.43 +/- 0.21 mu g/mL, AUC(0-48h): 13.65 +/- 3.12 mg/L h). This research indicated that phospholipid complex (PC) might be one of the suitable approachs to improve the oral bioavailability of KP and other poor-solubility flavonoids. (C) 2015 Elsevier B.V. All rights reserved.
机译:作为膳食类黄酮之一,山ka酚(KP)众所周知具有很强的抗氧化作用以及其他生物学特性。然而,由于KP的溶解性差,其口服生物利用度相对较低。在这项研究中,我们打算通过制备山奈酚-磷脂复合物(KP-PC)来增加KP的溶解度和生物利用度。 KP-PC的理化特性通过红外光谱(IR),差示扫描量热法(DSC)和粉末X射线衍射(PXRD),水/正辛醇溶解度和体外溶解度来表征。 KP-PC的溶解度和溶解度比KP高,表明亲水性显着提高。开发了一种UPLC-ESI-MS / MS方法,并通过该方法验证了Sprague-Dawley(SD)大鼠血浆中KP的测定,以研究KP-PC与KP的口服生物利用度。结果显示复合物中KP的C-max和AUC(0-48h)(C-max:3.94 +/- 0.83μg / mL,AUC(0-48h):57.81 +/- 9.43 mg / Lh)为高于KP(C-max:1.43 +/- 0.21μg / mL,AUC(0-48h):13.65 +/- 3.12 mg / L h)。这项研究表明,磷脂复合物(PC)可能是提高KP和其他可溶性差的类黄酮的口服生物利用度的合适方法之一。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号